There’s a patent fight brewing in the multibillion-dollar market for GLP-1 weight-loss drugs. Want the skinny?

Eli Lilly & Co.’s highly anticipated next-generation weight-loss shot didn’t increase overall heart risk in a new study, the ...

This concentration of activity in the off-plan segment reflects continued confidence in Dubai's development pipeline ...

New Bain brief outlines seven strategic decisions that will separate AI leaders from laggards as the window to build lasting ...

After 80 weeks of treatment, obese, non-diabetic participants receiving retatrutide lost an average of 22.6% of their body ...

George Johnson and the Rev. Jesse Jackson changed the trajectory of Black enterprise. The question now is: Who will carry ...

There are now positive results from five late-stage trials on retatrutide, which Lilly is positioning as the next pillar of ...

It's safe to say that the 2026 World Cup was an excellent platform for young players to shine under the brightest of ...

Bumblebees are among the world’s most important pollinators, helping to grow many crops and wild plants. But new research ...

The shift rightward was best captured by a New York magazine cover story that profiled the new generation of young Maga ...

Labour has to match the success of its New Deal for young people in the late 1990s, says Guardian columnist Polly Toynbee ...

New USDA data show the challenge isn't just losing farmland, but keeping it accessible and affordable for farmers.